Table 2. Correlation of ERalpha, RBCK1, RNF31 and SHARPIN mRNA expression levels in breast tumors.
Paired | Variables | 72 tumors | 47 ERalpha-positive tumors | ||
---|---|---|---|---|---|
Pearson correlation | P value | Pearson correlation | P value | ||
ERalpha | RBCK1 | 0.27 | 0.020* | 0.51 | < 0.001** |
ERalpha | RNF31 | 0.25 | 0.036* | 0.29 | 0.042* |
ERalpha | SHARPIN | 0.18 | 0.136 | 0.61 | < 0.001** |
RBCK1 | RNF31 | 0.15 | 0.202 | 0.16 | 0.270 |
RBCK1 | SHARPIN | 0.52 | < 0.001** | 0.57 | < 0.001** |
RNF31 | SHARPIN | 0.48 | < 0.001** | 0.56 | < 0.001** |
*Statistically significant (p < 0.05 in two-tailed test).
**Statistically significant (p < 0.01 in two-tailed test).